UY32555A - Nuevos derivados de quinazolinadiona - Google Patents
Nuevos derivados de quinazolinadionaInfo
- Publication number
- UY32555A UY32555A UY0001032555A UY32555A UY32555A UY 32555 A UY32555 A UY 32555A UY 0001032555 A UY0001032555 A UY 0001032555A UY 32555 A UY32555 A UY 32555A UY 32555 A UY32555 A UY 32555A
- Authority
- UY
- Uruguay
- Prior art keywords
- quinazolinadiona
- new derivatives
- medicaments
- cardiovascular disease
- solvate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención tiene por objeto la utilización de compuestos de la fórmula (I) en estado de base, de hidrato, de solvato, o de sus mezclas como medicamentos o para la preparación de medicamentos destinados al tratamiento de al menos una enfermedad cardiovascular y/o a prevenir la aparición de al menos una enfermedad cardiovascular.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0901755A FR2944206B1 (fr) | 2009-04-09 | 2009-04-09 | Applications therapeutiques dans le domaine cardiovasculaire de derives de quinazolinedione |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32555A true UY32555A (es) | 2010-11-30 |
Family
ID=41181038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032555A UY32555A (es) | 2009-04-09 | 2010-04-09 | Nuevos derivados de quinazolinadiona |
Country Status (35)
Country | Link |
---|---|
US (1) | US8846654B2 (es) |
EP (1) | EP2416777B1 (es) |
JP (1) | JP5685578B2 (es) |
KR (1) | KR101686267B1 (es) |
CN (1) | CN102458409B (es) |
AR (1) | AR076232A1 (es) |
AU (1) | AU2010233596B2 (es) |
BR (1) | BRPI1010256A2 (es) |
CA (1) | CA2758234A1 (es) |
CL (1) | CL2011002525A1 (es) |
CO (1) | CO6440577A2 (es) |
CR (1) | CR20110527A (es) |
CY (1) | CY1115987T1 (es) |
DK (1) | DK2416777T3 (es) |
DO (1) | DOP2011000306A (es) |
EA (1) | EA020984B1 (es) |
EC (1) | ECSP11011377A (es) |
ES (1) | ES2528633T3 (es) |
FR (1) | FR2944206B1 (es) |
HK (1) | HK1165997A1 (es) |
HR (1) | HRP20150106T1 (es) |
HU (1) | HUE024161T2 (es) |
IL (1) | IL215610A (es) |
MA (1) | MA33254B1 (es) |
MX (1) | MX2011010645A (es) |
NI (1) | NI201100180A (es) |
NZ (1) | NZ595660A (es) |
PL (1) | PL2416777T3 (es) |
PT (1) | PT2416777E (es) |
SG (2) | SG10201400420PA (es) |
SI (1) | SI2416777T1 (es) |
TN (1) | TN2011000506A1 (es) |
TW (1) | TWI457330B (es) |
UY (1) | UY32555A (es) |
WO (1) | WO2010116090A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2944282B1 (fr) * | 2009-04-09 | 2013-05-03 | Sanofi Aventis | Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques |
US9499496B2 (en) | 2012-06-05 | 2016-11-22 | University Of Kansas | Inhibitors of respiratory syncytial virus |
WO2014102589A1 (en) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Quinazolin-4(3h)-one-type piperidine compounds and uses thereof |
WO2024038089A1 (en) | 2022-08-18 | 2024-02-22 | Mitodicure Gmbh | Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3879393A (en) * | 1973-06-18 | 1975-04-22 | Miles Lab | Derivatives of 1,3-disubstituted 2,4(1h,3h)-quinazolinediones |
JPS56164172A (en) * | 1980-05-22 | 1981-12-17 | Masayuki Ishikawa | Novel 2,4 1h,3h -quinazolinedione derivative |
DE3172006D1 (en) * | 1980-05-22 | 1985-10-03 | Masayuki Ishikawa | Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof |
CA2118117A1 (en) | 1993-02-18 | 1994-08-19 | Shigeki Fujiwara | Adenosine uptake inhibitor |
CN1305454A (zh) | 1998-04-20 | 2001-07-25 | 藤泽药品工业株式会社 | 作为cgmp-磷酸二酯酶抑制剂的邻氨基苯甲酸衍生物 |
WO2001044228A2 (fr) | 1999-12-14 | 2001-06-21 | Sanofi-Synthelabo | Derives de quinazolinedione et phtalimide, leurs preparations et leurs applications en therapeutique |
MX2007010721A (es) | 2005-03-01 | 2007-11-13 | Pfizer Ltd | Nuevo uso de inhibidores de fosfodiesterasa 7 para el tratamiento de dolor neuropatico. |
WO2006092692A1 (en) | 2005-03-01 | 2006-09-08 | Pfizer Limited | Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain |
WO2007067946A2 (en) | 2005-12-07 | 2007-06-14 | The Regents Of The University Of California | Diagnosis and treatment of chronic lymphocytic leukemia (cll) |
MX2009010450A (es) | 2007-03-27 | 2009-11-23 | Omeros Corp | El uso de inhibidores de la fosfodiesterasa 7 para el tratamiento transtornos del movimiento. |
TW200911755A (en) | 2007-04-19 | 2009-03-16 | Astellas Pharma Inc | Bicyclic heterocyclic compounds |
FR2921926B1 (fr) | 2007-10-03 | 2009-12-04 | Sanofi Aventis | Derives de quinazolinedione,leur preparation et leurs applications therapeutiques. |
FR2943673B1 (fr) * | 2009-03-27 | 2013-03-29 | Sanofi Aventis | Applications therapeutiques de derives de quinazolinedione |
-
2009
- 2009-04-09 FR FR0901755A patent/FR2944206B1/fr not_active Expired - Fee Related
-
2010
- 2010-04-07 NZ NZ595660A patent/NZ595660A/xx not_active IP Right Cessation
- 2010-04-07 EP EP10723222.5A patent/EP2416777B1/fr active Active
- 2010-04-07 WO PCT/FR2010/050672 patent/WO2010116090A1/fr active Application Filing
- 2010-04-07 EA EA201171229A patent/EA020984B1/ru not_active IP Right Cessation
- 2010-04-07 SG SG10201400420PA patent/SG10201400420PA/en unknown
- 2010-04-07 SI SI201030847T patent/SI2416777T1/sl unknown
- 2010-04-07 AU AU2010233596A patent/AU2010233596B2/en not_active Ceased
- 2010-04-07 ES ES10723222.5T patent/ES2528633T3/es active Active
- 2010-04-07 PL PL10723222T patent/PL2416777T3/pl unknown
- 2010-04-07 SG SG2011073459A patent/SG175131A1/en unknown
- 2010-04-07 DK DK10723222.5T patent/DK2416777T3/en active
- 2010-04-07 HU HUE10723222A patent/HUE024161T2/hu unknown
- 2010-04-07 KR KR1020117026562A patent/KR101686267B1/ko active IP Right Grant
- 2010-04-07 BR BRPI1010256A patent/BRPI1010256A2/pt not_active IP Right Cessation
- 2010-04-07 JP JP2012504056A patent/JP5685578B2/ja not_active Expired - Fee Related
- 2010-04-07 PT PT107232225T patent/PT2416777E/pt unknown
- 2010-04-07 CN CN201080025111.8A patent/CN102458409B/zh not_active Expired - Fee Related
- 2010-04-07 CA CA2758234A patent/CA2758234A1/fr not_active Abandoned
- 2010-04-07 MX MX2011010645A patent/MX2011010645A/es active IP Right Grant
- 2010-04-07 MA MA34322A patent/MA33254B1/fr unknown
- 2010-04-08 TW TW099110928A patent/TWI457330B/zh not_active IP Right Cessation
- 2010-04-08 AR ARP100101179A patent/AR076232A1/es unknown
- 2010-04-09 UY UY0001032555A patent/UY32555A/es not_active Application Discontinuation
-
2011
- 2011-10-06 IL IL215610A patent/IL215610A/en not_active IP Right Cessation
- 2011-10-06 CR CR20110527A patent/CR20110527A/es unknown
- 2011-10-06 EC EC2011011377A patent/ECSP11011377A/es unknown
- 2011-10-06 NI NI201100180A patent/NI201100180A/es unknown
- 2011-10-06 DO DO2011000306A patent/DOP2011000306A/es unknown
- 2011-10-07 CL CL2011002525A patent/CL2011002525A1/es unknown
- 2011-10-07 TN TNP2011000506A patent/TN2011000506A1/fr unknown
- 2011-10-07 US US13/268,371 patent/US8846654B2/en not_active Expired - Fee Related
- 2011-10-07 CO CO11132796A patent/CO6440577A2/es not_active Application Discontinuation
-
2012
- 2012-07-09 HK HK12106684.4A patent/HK1165997A1/xx not_active IP Right Cessation
-
2015
- 2015-01-28 HR HRP20150106TT patent/HRP20150106T1/hr unknown
- 2015-02-12 CY CY20151100141T patent/CY1115987T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20140141A7 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas | |
CR11802A (es) | Derivados de indazoles sustituidos con fenilo o piridinilo | |
GT200900230A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso | |
IL215065A (en) | Proline derivatives, their preparation process, their pharmaceutical compositions and their uses in drug preparation | |
DK3045164T3 (da) | Vandige farmaceutiske sammensætninger, der indeholder borat-polyol-komplekser | |
ECSP10010058A (es) | Derivados de quinazolinadiona, su preparación y sus aplicaciones terapéuticas | |
CR11684A (es) | Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa | |
CU20100111A7 (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso para el tratamiento y prevención de enfermedades pulmonares y cardiovasculares | |
CU20110088A7 (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales | |
UY32052A (es) | 5-aminopirazoles sustituidos y uso de los mismos | |
JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
ECSP11011483A (es) | Piperidinas sustituidas | |
ECSP11011101A (es) | Compuestos cicloundecadepsipéptidos y el uso de dichos compuestos como un medicamento | |
GEP201606566B (en) | Isoxazolidine derivatives | |
DOP2010000400A (es) | 7-sulfanilmetil-,7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
UY32555A (es) | Nuevos derivados de quinazolinadiona | |
CU20110214A7 (es) | Piperidinas sustituidas | |
MA32461B1 (fr) | Dronedarone pour la prevention de cardioversion | |
PH12015500373A1 (en) | Diazepinone derivatives useful for the treatment of fragile x syndrome, parkinsons or reflux disease | |
NI201200103A (es) | NUEVOS DERIVADOS ( HETEROCICLO - TETRAHIDRO - PIRIDIN ) - ( PIPERAZINIL ) - 1 - ALCANONA Y ( HETEROCICLO - DIHIDRO - PIRROLIDIN ) - ( PIPERAZINIL ) - 1 - ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75 | |
CU20100260A7 (es) | 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
UY29858A1 (es) | Derivados de la 1-amino-ftalazina sustituida, su preparación y su aplicación en terapéutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20181127 |